Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brett (Based) (BRETT) vs Enzyme (MLN) Price & Performance

Brett (Based)Trade

Price performance (Past 24H)

Key statistics

Brett (Based) vs Enzyme — how do they compare? Brett (Based) trades at Rp67.86 (market cap Rp678,92M, Rp67,51M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Brett (Based) is far larger — about 5.1× Enzyme's market cap, and Brett (Based)'s supply is capped (10B / 10B BRETT (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Brett (Based) for 31 Days and Enzyme for 29 Days on average.

BRETTMLN
Market Cap
Rp678,92MRp134,13M
Volume (24h)
Rp67,51MRp104,56M
Circulating Supply
10B / 10B BRETT (100%)3,3M MLN
Typical Hold Time
31 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Brett (Based)

BRETT is currently trading at Rp69,836 with a market cap of Rp698.01M, showing bearish technical signals with all moving averages indicating sell pressure. The token has 100% circulating supply with average hold time of 31 days. Technical indicators show neutral oscillators but bearish ADX signals, with key support at Rp66 and resistance at Rp71.

Overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity and concentrated sell pressure. Investors should monitor for any ecosystem developments or exchange listings that could improve sentiment.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BRETT
28% Buy72% Sell
Avg holding period · 31 Days
MLN

No sentiment data available yet.

About Brett (Based)

BRETT is Pepe's best friend and a central cultural mascot of the Base Chain. As the Base Chain ecosystem continues to expand with various projects and applications, BRETT is able to benefit from this growth by leveraging shared resources and expertise. Its potential for adoption and community engagement is closely linked to the ongoing development of the Base Chain.

Read more on BRETT

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN